Alternative splicing as a therapeutic target for human diseases

Methods in Molecular Biology

Volumn 555, Issue , 2009, Pages 127-144

  Dery, Kenneth J ^a   Gusti, Veronica ^a   Gaur, Shikha ^a   Shively, John E ^a   Yen, Yun ^a   Gaur, Rajesh K ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Alternative splicing; RNAi; spliceosome; theophylline responsive riboswitch

Indexed keywords

EUKARYOTA;

APTAMER; CARCINOEMBRYONIC ANTIGEN BINDING PROTEIN, HUMAN; CELL SURFACE RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; THEOPHYLLINE;

ALTERNATIVE RNA SPLICING; ARTICLE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; HUMANS; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; THEOPHYLLINE; TRANSFECTION;

EID: 70349335808     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-295-7_10     Document Type: Article

References (41)

1. Black, D. L. (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336. (Pubitemid 36930448)
2. House, A. E. and Lynch, K. W. (2008) Regulation of alternative splicing: more than just the ABCs. J. Biol. Chem. 283, 1217-1221.
3. Wang, Z. and Burge, C. B. (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14, 802-813. (Pubitemid 351574901)
4. Mironov, A. A., Fickett, J. W. and Gelfand, M. S. (1999) Frequent alternative splicing of human genes. Genome Res. 9, 1288-1293. (Pubitemid 30042512)
5. Johnson, J. M., et al. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302, 2141-2144. (Pubitemid 38017950)
6. Kan, Z., et al. (2001) Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res. 11, 889-900. (Pubitemid 32447871)
7. Garcia-Blanco, M. A. (2006) Alternative splicing: therapeutic target and tool. Prog. Mol. Subcell. Biol. 44, 47-64.
8. Faustino, N. A. and Cooper, T. A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437. (Pubitemid 36258756)
9. Benz, E. J., Jr. and Huang, S. C. (1997) Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane. Trans. Am. Clin. Climatol. Assoc. 108, 78-95.
10. Kurreck, J. (2006) siRNA Efficiency: Structure or sequence-that is the question. J. Biomed. Biotechnol. 2006, 83757.
11. Leuschner, P. J., et al. (2006) Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep. 7, 314-320.
12. Gaur, R. K. (2006) RNA interference: a potential therapeutic tool for silencing splice isoforms linked to human diseases. Biotechniques Suppl, 15-22.
13. Kim, D. S., et al. (2008) Ligand-induced sequestering of branchpoint sequence allows conditional control of splicing. BMC Mol. Biol. 9, 23.
14. Kim, D. S., et al. (2005) An artificial riboswitch for controlling pre-mRNA splicing. RNA 11, 1667-1677.
15. Kole, R., Vacek, M. and Williams, T. (2004) Modification of alternative splicing by antisense therapeutics. Oligonucleotides 14, 65-74. (Pubitemid 38524636)
16. Dominski, Z. and Kole, R. (1993) Restoration of correct splicing in thalassemic premRNA by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 90, 8673-8677. (Pubitemid 23277732)
17. Tucker, B. J. and Breaker, R. R. (2005) Riboswitches as versatile gene control elements. Curr. Opin. Struct. Bio. 15, 342-348. (Pubitemid 40826454)
18. Nudler, E. and Mironov, A. S. (2004) The riboswitch control of bacterial metabolism. Trends Biochem. Sci. 29, 11-17. (Pubitemid 38068475)
19. Goguel, V., Wang, Y. and Rosbash, M. (1993) Short artificial hairpins sequester splicing signals and inhibit yeast pre-mRNA splicing. Mol. Cell. Biol. 13, 6841-6848. (Pubitemid 23321137)
20. Gusti, V., Kim, D. S. and Gaur, R. K. (2008) Sequestering of the 3-splice site in a theophylline-responsive riboswitch allows ligand-dependent control of alternative splicing. Oligonucleotides 18, 93-99.
21. Dignam, J. D., Lebovitz, R. M. and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
22. Fischer, D. C., et al. (2004) Expression of splicing factors in human ovarian cancer. Oncol. Rep. 11, 1085-1090.
23. Ghigna, C., et al. (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol. Cell 20, 881-890. (Pubitemid 41814877)
24. He, X., et al. (2004) Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin. Cancer Res. 10, 4652-4660. (Pubitemid 38955515)
25. Karni, R., et al. (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14, 185-193. (Pubitemid 46355578)
26. Zhu, H., et al. (2005) Enhancing TRAILinduced apoptosis by Bcl-X(L) siRNA. Cancer Biol. Ther. 4, 393-397.
27. Chevinsky, A. H. (1991) CEA in tumors of other than colorectal origin. Semin. Surg. Oncol. 7, 162-166.
28. Hammarstrom, S. (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9, 67-81. (Pubitemid 29265523)
29. Li, W. and Cha, L. (2007) Predicting siRNA efficiency. Cell. Mol. Life Sci. 64, 1785-1792.
30. Yiu, S.M., et al. (2005) Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics 21, 144-151. (Pubitemid 40202015)
31. Patzel, V., et al. (2005) Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency. Nat. Biotechnol. 23, 1440-1444. (Pubitemid 41679398)
32. Huesken, D., et al. (2005) Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23, 995-1001. (Pubitemid 41114034)
33. Tuschl, T. (2004) Targeting genes expressed in mammalian cells using siRNAs. Nat.Methods X, 13-17.
34. Reynolds, A., et al. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326-330. (Pubitemid 38295766)
35. Daoud, R., et al. (1999) Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 11, 788-802.
36. Venables, J. P. (2004) Aberrant and alternative splicing in cancer. Cancer Res. 64, 7647-7654. (Pubitemid 39446889)
37. Tazi, J., Durand, S. and Jeanteur, P. (2005) The spliceosome: a novel multi-faceted target for therapy. Trends Biochem. Sci. 30, 469-478. (Pubitemid 41033243)
38. Jenison, R. D., et al. (1994) High-resolution molecular discrimination by RNA. Science 263, 1425-1429. (Pubitemid 24137828)
39. Mayeda, A. and Krainer, A. R. (1999) Mammalian in vitro splicing assays. Methods Mol. Biol. 118, 315-321.
40. Ge, L. and Rudolph, P. (1997) Simultaneous introduction of multiple mutations using overlap extension PCR. Biotechniques 22, 28-30. (Pubitemid 27036405)
41. Visitsunthorn, N., Udomittipong, K. and Punnakan, L. (2001) Theophylline toxicity in Thai children. Asian Pac. J. Allergy Immunol. 19, 177-182. (Pubitemid 34065331)